_id
691052acccc777a4e85d54dc
Ticker
COEPW
Name
Coeptis Therapeutics Holdings Inc
Exchange
NASDAQ
Address
105 Bradford Road, Wexford, PA, United States, 15090
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://coeptispharma.com
Description
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.
Last Close
0.0146
Volume
23306
Current Price
0.0124
Change
-0.0002
Last Updated
2026-01-02T11:47:01.283Z
Image
-
Ipo Date
2020-12-17T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
237441
Cost Of Revenue
45155
Gross Profit
192286
Operating Expenses
2669314
Operating Income
-2477028
Interest Expense
62610
Pretax Income
-2898763
Net Income
-159360
Eps
-0.033584196207910956
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-2739403
EBITDA
-2530388
Operating Margin
-1043.2183152867449
Total Other Income Expense Net
-421735
Cash
4908487
Short Term Investments
421698
Receivables
86041
Inventories
-
Total Current Assets
5990862
Property Plant Equipment
39124
Total Assets
16282008
Payables
783103
Short Term Debt
129865
Long Term Debt
150000
Total Liabilities
3264864
Equity
12465950
Bs_currency_symbol
USD
Depreciation
305765
Change In Working Capital
-579880
Cash From Operations
-2152217
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
5063978
Net Change In Cash
2911761
Cf_currency_symbol
USD
PE
-
PB
0.004719985528579851
ROE
-1.2783622587929522
ROA
-0.978749058469938
FCF
-2152220
Fcf Percent
-9.064230693098496
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
237441
Quarters > 0 > income Statement > cost Of Revenue
45155
Quarters > 0 > income Statement > gross Profit
192286
Quarters > 0 > income Statement > operating Expenses
2669314
Quarters > 0 > income Statement > operating Income
-2477028
Quarters > 0 > income Statement > interest Expense
62610
Quarters > 0 > income Statement > pretax Income
-2898763
Quarters > 0 > income Statement > net Income
-159360
Quarters > 0 > income Statement > eps
-0.033584196207910956
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4745089
Quarters > 0 > income Statement > income Tax Expense
-2739403
Quarters > 0 > income Statement > EBITDA
-2530388
Quarters > 0 > income Statement > operating Margin
-1043.2183152867449
Quarters > 0 > income Statement > total Other Income Expense Net
-421735
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4908487
Quarters > 0 > balance Sheet > short Term Investments
421698
Quarters > 0 > balance Sheet > receivables
86041
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5990862
Quarters > 0 > balance Sheet > property Plant Equipment
39124
Quarters > 0 > balance Sheet > total Assets
16282008
Quarters > 0 > balance Sheet > payables
783103
Quarters > 0 > balance Sheet > short Term Debt
129865
Quarters > 0 > balance Sheet > long Term Debt
150000
Quarters > 0 > balance Sheet > total Liabilities
3264864
Quarters > 0 > balance Sheet > equity
12465950
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2739403
Quarters > 0 > cash Flow > depreciation
305765
Quarters > 0 > cash Flow > change In Working Capital
-579880
Quarters > 0 > cash Flow > cash From Operations
-2152217
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
5063978
Quarters > 0 > cash Flow > net Change In Cash
2911761
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.033584196207910956
Quarters > 0 > ratios > PB
0.004719985528579851
Quarters > 0 > ratios > ROE
-1.2783622587929522
Quarters > 0 > ratios > ROA
-0.978749058469938
Quarters > 0 > ratios > FCF
-2152220
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-9.064230693098496
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
200681
Quarters > 1 > income Statement > cost Of Revenue
45157
Quarters > 1 > income Statement > gross Profit
155524
Quarters > 1 > income Statement > operating Expenses
4676738
Quarters > 1 > income Statement > operating Income
-4521214
Quarters > 1 > income Statement > interest Expense
67788
Quarters > 1 > income Statement > pretax Income
-4334586
Quarters > 1 > income Statement > net Income
-3534595
Quarters > 1 > income Statement > eps
-0.9535447738545023
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3706795
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3961271
Quarters > 1 > income Statement > operating Margin
-2252.9357537584524
Quarters > 1 > income Statement > total Other Income Expense Net
186628
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1996726
Quarters > 1 > balance Sheet > short Term Investments
990566
Quarters > 1 > balance Sheet > receivables
30000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3694935
Quarters > 1 > balance Sheet > property Plant Equipment
49731
Quarters > 1 > balance Sheet > total Assets
12191479
Quarters > 1 > balance Sheet > payables
1028826
Quarters > 1 > balance Sheet > short Term Debt
1163745
Quarters > 1 > balance Sheet > long Term Debt
150000
Quarters > 1 > balance Sheet > total Liabilities
5111349
Quarters > 1 > balance Sheet > equity
6095830
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4334586
Quarters > 1 > cash Flow > depreciation
305527
Quarters > 1 > cash Flow > change In Working Capital
-769219
Quarters > 1 > cash Flow > cash From Operations
-2396742
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
125100
Quarters > 1 > cash Flow > net Change In Cash
-2271642
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.9535447738545023
Quarters > 1 > ratios > PB
0.007540278846358904
Quarters > 1 > ratios > ROE
-57.98381844638057
Quarters > 1 > ratios > ROA
-28.992339649684833
Quarters > 1 > ratios > FCF
-2396742
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-11.943043935399963
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
62874
Quarters > 2 > income Statement > cost Of Revenue
1359708
Quarters > 2 > income Statement > gross Profit
-1296834
Quarters > 2 > income Statement > operating Expenses
2760149
Quarters > 2 > income Statement > operating Income
-4056984
Quarters > 2 > income Statement > interest Expense
71491
Quarters > 2 > income Statement > pretax Income
-3420941
Quarters > 2 > income Statement > net Income
-3057730
Quarters > 2 > income Statement > eps
-0.9950069539490426
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3073074
Quarters > 2 > income Statement > income Tax Expense
-363000
Quarters > 2 > income Statement > EBITDA
-3044157
Quarters > 2 > income Statement > operating Margin
-6452.562267391927
Quarters > 2 > income Statement > total Other Income Expense Net
636043
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
4268368
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4650996
Quarters > 2 > balance Sheet > property Plant Equipment
60102
Quarters > 2 > balance Sheet > total Assets
13453067
Quarters > 2 > balance Sheet > payables
1120657
Quarters > 2 > balance Sheet > short Term Debt
1871435
Quarters > 2 > balance Sheet > long Term Debt
150000
Quarters > 2 > balance Sheet > total Liabilities
5990153
Quarters > 2 > balance Sheet > equity
6478614
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3058000
Quarters > 2 > cash Flow > depreciation
305297
Quarters > 2 > cash Flow > change In Working Capital
-220755
Quarters > 2 > cash Flow > cash From Operations
-2366167
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
6101650
Quarters > 2 > cash Flow > net Change In Cash
3735483
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.9950069539490426
Quarters > 2 > ratios > PB
0.005881831762163944
Quarters > 2 > ratios > ROE
-47.19728633315706
Quarters > 2 > ratios > ROA
-22.728869186483646
Quarters > 2 > ratios > FCF
-2366167
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-37.63347329579795
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1863000
Quarters > 3 > income Statement > cost Of Revenue
259982
Quarters > 3 > income Statement > gross Profit
-259982
Quarters > 3 > income Statement > operating Expenses
1902232
Quarters > 3 > income Statement > operating Income
-2162214
Quarters > 3 > income Statement > interest Expense
78629
Quarters > 3 > income Statement > pretax Income
-3011765
Quarters > 3 > income Statement > net Income
-3011765
Quarters > 3 > income Statement > eps
-1.4232009303508049
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2116191
Quarters > 3 > income Statement > income Tax Expense
-1064000
Quarters > 3 > income Statement > EBITDA
-2673157
Quarters > 3 > income Statement > operating Margin
-116.06086956521739
Quarters > 3 > income Statement > total Other Income Expense Net
-849551
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
532885
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1051292
Quarters > 3 > balance Sheet > property Plant Equipment
59783
Quarters > 3 > balance Sheet > total Assets
8908660
Quarters > 3 > balance Sheet > payables
1269763
Quarters > 3 > balance Sheet > short Term Debt
1230178
Quarters > 3 > balance Sheet > long Term Debt
150000
Quarters > 3 > balance Sheet > total Liabilities
5041434
Quarters > 3 > balance Sheet > equity
3185164
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3011765
Quarters > 3 > cash Flow > depreciation
259982
Quarters > 3 > cash Flow > change In Working Capital
-44293
Quarters > 3 > cash Flow > cash From Operations
-1436538
Quarters > 3 > cash Flow > capital Expenditures
1
Quarters > 3 > cash Flow > cash From Investing
100000
Quarters > 3 > cash Flow > cash From Financing
731971
Quarters > 3 > cash Flow > net Change In Cash
-604568
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.4232009303508049
Quarters > 3 > ratios > PB
0.008238435571920315
Quarters > 3 > ratios > ROE
-94.55604169832385
Quarters > 3 > ratios > ROA
-33.80716067287336
Quarters > 3 > ratios > FCF
-1436539
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.77108910359635
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1038632
Annuals > 0 > income Statement > gross Profit
-1038632
Annuals > 0 > income Statement > operating Expenses
9015855
Annuals > 0 > income Statement > operating Income
-10054488
Annuals > 0 > income Statement > interest Expense
396116
Annuals > 0 > income Statement > pretax Income
-10877412
Annuals > 0 > income Statement > net Income
-10877412
Annuals > 0 > income Statement > eps
-5.651663506766724
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1924639
Annuals > 0 > income Statement > income Tax Expense
-1064000
Annuals > 0 > income Statement > EBITDA
-9442662
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-822924
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
532885
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
38978
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1051292
Annuals > 0 > balance Sheet > property Plant Equipment
59783
Annuals > 0 > balance Sheet > total Assets
8908660
Annuals > 0 > balance Sheet > payables
1269763
Annuals > 0 > balance Sheet > short Term Debt
1230178
Annuals > 0 > balance Sheet > long Term Debt
150000
Annuals > 0 > balance Sheet > total Liabilities
5041434
Annuals > 0 > balance Sheet > equity
3185164
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-10877412
Annuals > 0 > cash Flow > depreciation
1038633
Annuals > 0 > cash Flow > change In Working Capital
-125262
Annuals > 0 > cash Flow > cash From Operations
-6649281
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
5713032
Annuals > 0 > cash Flow > net Change In Cash
-936249
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-5.651663506766724
Annuals > 0 > ratios > PB
0.006525912386300988
Annuals > 0 > ratios > ROE
-341.5024155742059
Annuals > 0 > ratios > ROA
-122.09930561947589
Annuals > 0 > ratios > FCF
-6649285
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1001236
Annuals > 1 > income Statement > gross Profit
-1001236
Annuals > 1 > income Statement > operating Expenses
20489888
Annuals > 1 > income Statement > operating Income
-21491125
Annuals > 1 > income Statement > interest Expense
107685
Annuals > 1 > income Statement > pretax Income
-21266537
Annuals > 1 > income Statement > net Income
-21266537
Annuals > 1 > income Statement > eps
-16.556289261416318
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1284499
Annuals > 1 > income Statement > income Tax Expense
3393542
Annuals > 1 > income Statement > EBITDA
-20157618
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
224588
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3791302
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
8075
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3941733
Annuals > 1 > balance Sheet > property Plant Equipment
71456
Annuals > 1 > balance Sheet > total Assets
7915689
Annuals > 1 > balance Sheet > payables
99021
Annuals > 1 > balance Sheet > short Term Debt
1541618
Annuals > 1 > balance Sheet > long Term Debt
150000
Annuals > 1 > balance Sheet > total Liabilities
3112360
Annuals > 1 > balance Sheet > equity
4803329
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-37574217
Annuals > 1 > cash Flow > depreciation
1001384
Annuals > 1 > cash Flow > change In Working Capital
-550335
Annuals > 1 > cash Flow > cash From Operations
-3875811
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5487555
Annuals > 1 > cash Flow > net Change In Cash
1611744
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-16.556289261416318
Annuals > 1 > ratios > PB
0.002888119718636804
Annuals > 1 > ratios > ROE
-442.7457915125114
Annuals > 1 > ratios > ROA
-268.6631195338776
Annuals > 1 > ratios > FCF
-3875811
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1001384
Annuals > 2 > income Statement > gross Profit
-1001384
Annuals > 2 > income Statement > operating Expenses
33194580
Annuals > 2 > income Statement > operating Income
-34195964
Annuals > 2 > income Statement > interest Expense
218412
Annuals > 2 > income Statement > pretax Income
-37574217
Annuals > 2 > income Statement > net Income
-37574217
Annuals > 2 > income Statement > eps
-52.567306441255596
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
714783
Annuals > 2 > income Statement > income Tax Expense
3394000
Annuals > 2 > income Statement > EBITDA
-36354422
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-3378253
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3791302
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
8075
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
3941733
Annuals > 2 > balance Sheet > property Plant Equipment
71456
Annuals > 2 > balance Sheet > total Assets
7915689
Annuals > 2 > balance Sheet > payables
99021
Annuals > 2 > balance Sheet > short Term Debt
1541618
Annuals > 2 > balance Sheet > long Term Debt
150000
Annuals > 2 > balance Sheet > total Liabilities
3112360
Annuals > 2 > balance Sheet > equity
4803329
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-37574217
Annuals > 2 > cash Flow > depreciation
1001384
Annuals > 2 > cash Flow > change In Working Capital
-550335
Annuals > 2 > cash Flow > cash From Operations
-3875811
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
5487555
Annuals > 2 > cash Flow > net Change In Cash
1611744
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-52.567306441255596
Annuals > 2 > ratios > PB
0.0016071471265033065
Annuals > 2 > ratios > ROE
-782.2536619915063
Annuals > 2 > ratios > ROA
-474.68030894088946
Annuals > 2 > ratios > FCF
-3875811
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
75000
Annuals > 3 > income Statement > cost Of Revenue
447413
Annuals > 3 > income Statement > gross Profit
-372413
Annuals > 3 > income Statement > operating Expenses
13673519
Annuals > 3 > income Statement > operating Income
-14045932
Annuals > 3 > income Statement > interest Expense
187133
Annuals > 3 > income Statement > pretax Income
-13449280
Annuals > 3 > income Statement > net Income
-13449280
Annuals > 3 > income Statement > eps
-24.644658144716782
Annuals > 3 > income Statement > dividends Per Share
77595
Annuals > 3 > income Statement > shares Outstanding
545728
Annuals > 3 > income Statement > income Tax Expense
972919
Annuals > 3 > income Statement > EBITDA
-12814739
Annuals > 3 > income Statement > operating Margin
-18727.909333333333
Annuals > 3 > income Statement > total Other Income Expense Net
596652
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2179558
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
2179558
Annuals > 3 > balance Sheet > property Plant Equipment
31851
Annuals > 3 > balance Sheet > total Assets
6765576
Annuals > 3 > balance Sheet > payables
134092
Annuals > 3 > balance Sheet > short Term Debt
2431724
Annuals > 3 > balance Sheet > long Term Debt
1650000
Annuals > 3 > balance Sheet > total Liabilities
4414942
Annuals > 3 > balance Sheet > equity
2350634
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-13449280
Annuals > 3 > cash Flow > depreciation
447413
Annuals > 3 > cash Flow > change In Working Capital
-2979696
Annuals > 3 > cash Flow > cash From Operations
-4489440
Annuals > 3 > cash Flow > capital Expenditures
1750000
Annuals > 3 > cash Flow > cash From Investing
-1750000
Annuals > 3 > cash Flow > cash From Financing
8216033
Annuals > 3 > cash Flow > net Change In Cash
1976593
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-24.644658144716782
Annuals > 3 > ratios > PB
0.002507350102142656
Annuals > 3 > ratios > ROE
-572.1554270039487
Annuals > 3 > ratios > ROA
-198.78987391465265
Annuals > 3 > ratios > FCF
-6239440
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-83.19253333333333
Annuals > 3 > health Score
24
Valuation > metrics > PE
-0.033584196207910956
Valuation > metrics > PB
0.004719985528579851
Valuation > final Score
70
Valuation > verdict
99.5% Undervalued
Profitability > metrics > ROE
-1.2783622587929522
Profitability > metrics > ROA
-2.6600512580660345
Profitability > metrics > Net Margin
-0.6711562030146436
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2619025425258404
Risk > metrics > Interest Coverage
-39.56281744130331
Risk > final Score
-98
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.5619627413009
Liquidity > metrics > Quick Ratio
6.5619627413009
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-219
Prev Risks > 1
-179
Prev Risks > 2
-80
Prev Liquidities > 0
92
Prev Liquidities > 1
89
Prev Liquidities > 2
31
Updated At
2026-01-20T21:38:20.439Z
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFibonacci Support Holding Strong in Bajaj Consumer Care Limited - Trade Exit Report & Verified Swing Trading Watchlist bollywoodhelpline.com
Read more →How does GOOG perform in inflationary periods - 2025 Biggest Moves & Risk Managed Investment Entry Signals bollywoodhelpline.com
Read more →Showing 2 of 7
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Coeptis Therapeutics Holdings Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.